Evolent Health Inc(EVH)今日盘中大涨5.46%,引发市场广泛关注。据悉,这主要是因为重要分析机构巴克莱将该公司的目标价从39美元大幅下调至19美元。
Evolent Health是一家医疗管理和人工智能服务公司,在医疗大数据分析和成本控制等领域具有一定优势。然而近期其营收和利润增长放缓,加之行业竞争加剧,市场曾对其未来发展前景持谨慎态度。
但在巴克莱大幅下调其目标价后,投资者对Evolent Health的估值和未来预期或已重新调整。有分析人士认为,低目标价可能反映公司业绩和估值已充分消化不利因素,未来如能改善营收状况和扭转亏损,其股价仍有较大上行空间。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.